| Literature DB >> 29048558 |
Pinar Mesci1,2, Angela Macia1,2, Christopher N LaRock3, Leon Tejwani1,2, Isabella R Fernandes1,2, Nicole A Suarez1,2, Paolo M de A Zanotto4, Patricia C B Beltrão-Braga5,6,7, Victor Nizet3, Alysson R Muotri1,2.
Abstract
Although Zika virus (ZIKV) infection is often asymptomatic, in some cases, it can lead to birth defects in newborns or serious neurologic complications in adults. However, little is known about the interplay between immune and neural cells that could contribute to the ZIKV pathology. To understand the mechanisms at play during infection and the antiviral immune response, we focused on neural precursor cells (NPCs)-microglia interactions. Our data indicate that human microglia infected with the current circulating Brazilian ZIKV induces a similar pro-inflammatory response found in ZIKV-infected human tissues. Importantly, using our model, we show that microglia interact with ZIKV-infected NPCs and further spread the virus. Finally, we show that Sofosbuvir, an FDA-approved drug for Hepatitis C, blocked viral infection in NPCs and therefore the transmission of the virus from microglia to NPCs. Thus, our model provides a new tool for studying neuro-immune interactions and a platform to test new therapeutic drugs.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29048558 PMCID: PMC5886060 DOI: 10.1093/hmg/ddx382
Source DB: PubMed Journal: Hum Mol Genet ISSN: 0964-6906 Impact factor: 6.150